Literature DB >> 2155924

Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice.

T Akaike1, M Ando, T Oda, T Doi, S Ijiri, S Araki, H Maeda.   

Abstract

We evaluated various biochemical parameters in influenza virus-infected mice and focused on adenosine catabolism in the supernatant of bronchoalveolar lavage fluid (s-BALF), lung tissue, and serum (plasma). The activities of adenosine deaminase (ADA) and xanthine oxidase (XO), which generates O2-, were elevated in the s-BALF, lung tissue homogenate, and serum (plasma). The elevations were most remarkable in s-BALF and in lung tissue: We found a 170-fold increase in ADA activity and a 400-fold increase in XO activity as measured per volume of alveolar lavage fluid. The ratio of activity of XO to activity of xanthine dehydrogenase in s-BALF increased from 0.15 +/- 0.05 (control; no infection) to 1.06 +/- 0.13 on day 6 after viral infection. Increased levels of various adenosine catabolites (i.e., inosine, hypoxanthine, xanthine, and uric acid) in serum and s-BALF were confirmed. We also identified O2- generation from XO in s-BALF obtained on days 6 and 8 after infection, and the generation of O2- was enhanced remarkably in the presence of adenosine. Lastly, treatment with allopurinol (an inhibitor of XO) and with chemically modified superoxide dismutase (a scavenger of O2-) improved the survival rate of influenza virus-infected mice. These results indicate that generation of oxygen-free radicals by XO, coupled with catabolic supply of hypoxanthine from adenosine catabolism, is a pathogenic principle in influenza virus infection in mice and that a therapeutic approach by elimination of oxygen radicals thus seems possible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155924      PMCID: PMC296490          DOI: 10.1172/JCI114499

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus.

Authors:  J Hurd; R B Heath
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.

Authors:  F W Denny; D Taylor-Robinson; A C Allison
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

4.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation.

Authors:  G Biberfeld; P Biberfeld; G Sterner
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

6.  Effect of antilymphocyte serum on influenza virus infection in mice.

Authors:  F Suzuki; J Oya; N Ishida
Journal:  Proc Soc Exp Biol Med       Date:  1974-05

7.  Fluorometric assay for xanthine oxidase.

Authors:  J L Haining; J S Legan
Journal:  Anal Biochem       Date:  1967-12       Impact factor: 3.365

8.  Serum adenosine deaminase activity with Mycoplasma pneumoniae.

Authors:  H Nishikawa; M Suga; M Ando; F Tanaka; S Araki
Journal:  Chest       Date:  1988-12       Impact factor: 9.410

9.  Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice.

Authors:  T Akaike; A Molla; M Ando; S Araki; H Maeda
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Quantitative aspects of the multiplication of influenza A virus in the mouse lung; relation between the degree of viral multiplication and the extent of pneumonia.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

View more
  92 in total

Review 1.  Role of xanthine oxidoreductase as an antimicrobial agent.

Authors:  Hannah M Martin; John T Hancock; Vyv Salisbury; Roger Harrison
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Lipid-derived free radical production in superantigen-induced interstitial pneumonia.

Authors:  Hisako Miyakawa; Ronald P Mason; Jinjie Jiang; Maria B Kadiiska
Journal:  Free Radic Biol Med       Date:  2009-04-17       Impact factor: 7.376

3.  TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants.

Authors:  Sarah C Higgins; Kingston H G Mills
Journal:  Curr Infect Dis Rep       Date:  2010-01       Impact factor: 3.725

4.  Untargeted metabolomics analysis of the upper respiratory tract of ferrets following influenza A virus infection and oseltamivir treatment.

Authors:  David J Beale; Ding Yuan Oh; Avinash V Karpe; Celeste Tai; Michael S Dunn; Danielle Tilmanis; Enzo A Palombo; Aeron C Hurt
Journal:  Metabolomics       Date:  2019-03-01       Impact factor: 4.290

5.  Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection.

Authors:  Pankaj Kumar; Sonal Sharma; MadhU Khanna; Hanumantharao Guru Raj
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

6.  Granulation in livers of mice infected with Salmonella typhimurium is caused by superoxide released from host phagocytes.

Authors:  K Umezawa; N Ohnishi; K Tanaka; S Kamiya; Y Koga; H Nakazawa; A Ozawa
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 7.  Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.

Authors:  Enrico Garattini; Ralf Mendel; Maria João Romão; Richard Wright; Mineko Terao
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

Review 8.  Innate sensors of influenza virus: clues to developing better intranasal vaccines.

Authors:  Takeshi Ichinohe; Akiko Iwasaki; Hideki Hasegawa
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

9.  Identification of the rat xanthine dehydrogenase/oxidase promoter.

Authors:  C W Chow; M Clark; J Rinaldo; R Chalkley
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

Review 10.  The role for N-acetylcysteine in the management of COPD.

Authors:  P N R Dekhuijzen; W J C van Beurden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.